MedCity News

Close-up of caregiver holding senior client hand. Support from nurse to patient, taking care of elderly man in hospital. Emotional support and care in healthcare, hospice care.

Healthcare’s Trust Crisis Is an Experience Crisis

Looser Health IT Certification Requirements Shift Oversight to Health Systems

The U.S. Department of Health and Human Services (HHS) is rolling back several health IT certification requirements that could reduce certification costs for technology developers. But they may leave hospitals and health systems holding more responsibility for evaluating the safety and performance of the AI tools they purchase.

By Jenna Congdon

Health Tech

Little pink ceramic piggy bank pattern on the left side on yellow background. Concept of saving money, savings.

4 Notable Health Tech Funding Announcements in October

Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding rounds.

By Marissa Plescia

Latest Video

Latest News

Consumer / Employer

MedCity FemFwd: The Gaps in Endometriosis Care

In this episode, we’re joined by Dr. Rani Aravamudhan, senior medical director of Artemis at Nomi Health. We discuss Nomi Health’s new research on endometriosis.

By Marissa Plescia

BioPharma, Pharma

Inovio’s DNA-Based Immunotherapy Lands Speedy FDA Nod for Rare Type of Tumor

Inovio’s Voceryq will compete with a Precigen product that last year became the first FDA-approved drug for recurrent respiratory papillomatosis, or RRP. While the two immunotherapies carry the same $460,000 list price, Inovio executives claim their product has another competitive advantage.

By Frank Vinluan

MedCity Influencers

Why Pharma Companies Should Look To Social Media For Better Patient Insight

Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.

By Rohit Marwah

Artificial Intelligence

7 Potential Problems with Medicare’s AI Prior Authorization Experiment

The federal government is testing whether artificial intelligence can help Medicare identify unnecessary medical care, speed up the prior authorization process, and reduce healthcare spending. But a new report based on evidence recovered from a lawsuit raises concerns about the AI experiment.

By Jenna Congdon

Hospitals

Integris Health to Join Risant Health as Health System Dealmaking Stays Active

As health system dealmaking stays steady in 2026, Integris Health is joining Risant Health to accelerate value-based care. The partnership represents an integration of Risant Health's capabilities into Integris' existing system, rather than a traditional merger.

By Jenna Congdon

Opinion

CMS Is Regulating the Wrong Thing — Here’s How to Fix Remote Patient Monitoring Without Losing the Care

Why should Medicare determine who is qualified to provide remote monitoring by asking who employs the nurse, rather than who is accountable for the patient's care?

By Anish Sebastian

How Innovation in BTK Inhibitor Development Is Improving Treatment Outcomes

BTK inhibitor has become an important treatment option for certain B-cell malignancies.

By Samuel Turner

MedCity Influencers

Mental Health Care Was Never Built for Everyone — AI Won’t Fix That

Companies aren't slowing down to ask if AI is ready for mental health; they're racing to build it in. Encoding the same unexamined standards into these tools means repeating the systemic issues marginalized groups have lived with for far too long.

By Josephine Mora

Health Tech

Midstream Health Snags $20M to Provide Health Systems More Financial Stability

Midstream's Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and CommonSpirit Ventures.

By Marissa Plescia

BioPharma, Startups

Rare Disease Biotech Setara Starts Out With $90M and a Lead Drug in the Clinic

Setara Biosciences’ lead program is a potential treatment for the rare neuromuscular disorder Charcot-Marie-Tooth disease type 2C and the prevalent condition overactive bladder. This small molecule came from Actio Biosciences, which was recently acquired by Jazz Pharmaceuticals.

By Frank Vinluan

Devices & Diagnostics

MMI Raises $125M to Expand Robotic Microsurgery and Explore New Treatments

Medical Microinstruments (MMI) has raised $125 million in Series D financing to expand the reach of its Symani Surgical System and investigate new applications for microsurgery, including an experimental approach to treat Alzheimer’s disease.

By Jenna Congdon

MedCity Influencers

What the Midterms Mean for Healthcare and the Investors Betting on It

One question on everyone’s mind is what the impact of the midterm elections will be on the US healthcare system in the near and long term - here are 3 possible outcomes

By Jason Robart

MedCity Influencers

Prestige Is a Business Model

An employer that treats board disclosure, community benefit reporting, and contracting terms as three separate conversations is missing that they are the same conversation.

By Dana Y. Lujan

Consumer / Employer, Policy

close-up studio macro shot of various pills on US dollar bills.

Employer, Pharmacy Advocates Applaud DOL Final Rule on PBMs

The Department of Labor finalized a rule that seeks to bring more transparency into PBM compensation.

By Marissa Plescia

BioPharma, Pharma

Bambusa IPO Brings In $169M to Break Immunology’s ‘Therapeutic Ceiling’

Bambusa Therapeutics’ IPO cash will support its pipeline of bispecific antibodies designed to offer advantages over currently available monoclonal antibodies. Aspen Neuroscience also debuted on the Nasdaq as it prepares for a pivotal test of its Parkinson’s disease cell therapy.

By Frank Vinluan

MedCity Influencers

It’s A TRAP! Employer Concerns for Tuition Reimbursement and Other Employee Repayment Agreements

For life science employers who offer these benefits should pay particular attention to new state laws and regulations to ensure continued compliance.

By Paul R. Piccigallo